Open Government Portal
This report, which is tabled under section 20 of the Service Fees Act and section 4.2.8 of the Directive on …
Whereas the Minister of Health believes that immediate action is required to deal with a significant risk, direct or indirect, …
Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also …
The purpose of this notice is to communicate minimum values of sensitivity for COVID-19 antigen testing devices.
Under the Interim Order, manufacturers and importers must report medical device shortages related to COVID-19 to Health Canada. The devices …
This guidance document presents the criteria for safety and effectiveness that apply to test swabs used for COVID-19 sampling. It …
Most PPE, including face shields, are Class I medical devices if they are manufactured, sold or represented for use for …
This document provides guidance for Canadian manufacturers on the minimum technical requirements for facepiece filtering respirators (FFR). Health Canada has …
COVID-19 is a new disease not previously identified in humans. Health Canada is closely tracking all potential drugs and vaccines …
The COVID-19 pandemic is adding to the ongoing public health crisis related to high rates of opioid overdose and deaths, …